Drugs / Heat Shock Protein 70-peptide complexes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00027131 | Dec 2000 → Oct 2002 | breast neoplasm | UConn Health | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Heat Shock Protein 70-peptide complexes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00027131 ↗ |
| Known as | HSP70 | “Heat Shock Protein 70-peptide complexes (HSP70)” NCT00027131 ↗ |
| Modality | Vaccine | “this particular vaccine, which is made from purified heat shock proteins taken from each patient's tumor” NCT00027131 ↗ |